A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
Su Jong Yu
Clin Mol Hepatol. 2016;22(1):7-17.   Published online 2016 Mar 28     DOI: https://doi.org/10.3350/cmh.2016.22.1.7
Citations to this article as recorded by Crossref logo
The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular Carcinoma
In-Gyu Kim, Xu-Guang Hu, Hee-Jung Wang, Bong-Wan Kim, Sung Yeon Hong, Xue-Yin Shen
Yonsei Medical Journal.2019; 60(2): 140.     CrossRef
Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation
Nieun Seo, Myoung Soo Kim, Mi-Suk Park, Jin-Young Choi, Chansik An, Kyunghwa Han, Seung Up Kim, Dong Jin Joo, Myeong-Jin Kim
European Radiology.2019; 29(2): 1022.     CrossRef
Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma
Sung-Mi Jung, Jong Man Kim, Gyu-Seong Choi, Choon Hyuck David Kwon, Nam-Joon Yi, Kwang-Woong Lee, Kyung Suk Suh, Jae-Won Joh
Journal of Gastrointestinal Surgery.2019; 23(2): 304.     CrossRef
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
Yohan Kim, Kyojin Kang, Seung Bum Lee, Daekwan Seo, Sangtae Yoon, Sung Joo Kim, Kiseok Jang, Yun Kyung Jung, Kyeong Geun Lee, Valentina M. Factor, Jaemin Jeong, Dongho Choi
Journal of Hepatology.2019; 70(1): 97.     CrossRef
Publisher's Note
Journal of Surgical Research.2019; 233: 381.     CrossRef
Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI
So Hee Song, Woo Kyoung Jeong, Dongil Choi, Young Kon Kim, Hee Chul Park, Jeong Il Yu
Acta Radiologica.2019; 60(7): 826.     CrossRef
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma
Toshifumi Hoki, Eriko Katsuta, Li Yan, Kazuaki Takabe, Fumito Ito
Journal of Surgical Research.2019; 234: 343.     CrossRef
Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC
Dong Ho Lee, Jeong Min Lee, Mi Hye Yu, Bo Yun Hur, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon, Yoon Jun Kim, Jeong-Hoon Lee, Su Jong Yu, Joon Koo Han
European Radiology.2019; 29(6): 3122.     CrossRef
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Dong Hyun Sinn, Gyu-Seong Choi, Hee Chul Park, Jong Man Kim, Honsoul Kim, Kyoung Doo Song, Tae Wook Kang, Min Woo Lee, Hyunchul Rhim, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Woo Kyoung Jeong, Seong Hyun Kim, Jeong Il Yu, Sang Yun Ha, Su Jin Lee, Ho Yeon
PLOS ONE.2019; 14(1): e0210730.     CrossRef
Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case series
Daniel Jiahao Wong, Joycelyn Lee, Su Pin Choo, Choon Hua Thng, Tiffany Hennedige
Immunotherapy.2019; 11(3): 167.     CrossRef
Young-Sun Lee, Myung Han Hyun, Sun Young Yim, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
Hepatology.2019; 69(2): 924.     CrossRef
Ceramide-Graphene Oxide Nanoparticles Enhance Cytotoxicity and Decrease HCC Xenograft Development: A Novel Approach for Targeted Cancer Therapy
Shi-Bing Wang, Ying-Yu Ma, Xiao-Yi Chen, Yuan-Yuan Zhao, Xiao-Zhou Mou
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Future Liver Remnant Hypertrophy after Portal Vein Embolization Is Inversely Correlated with Intrahepatic Tumor Burden
Edwin A. Takahashi, Chad J. Fleming, James C. Andrews
Journal of Vascular and Interventional Radiology.2019; 30(3): 435.     CrossRef
Endoscopic Ultrasound for the Diagnosis and Staging of Liver Tumors
Andrew Lange, Thiruvengadam Muniraj, Harry R. Aslanian
Gastrointestinal Endoscopy Clinics of North America.2019; 29(2): 339.     CrossRef
Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
Jeong-Ju Yoo, Su Yu, Juri Na, Kyungmin Kim, Young Cho, Yun Lee, Eun Cho, Jeong-Hoon Lee, Yoon Kim, Hyewon Youn, Jung-Hwan Yoon
International Journal of Molecular Sciences.2019; 20(6): 1292.     CrossRef
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Young Eun Chon, Hana Park, Hye Kyung Hyun, Yeonjung Ha, Mi Na Kim, Beom Kyung Kim, Joo Ho Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Seong Gyu Hwang, Kwang-Hyub Han, Kyu Sung Rim, Jun Yong Park
Cancers.2019; 11(4): 509.     CrossRef
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini
PLOS ONE.2019; 14(4): e0214613.     CrossRef
Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
Jiwoon Choi, Taek Chung, Hyungjin Rhee, Young-Joo Kim, Youngsic Jeon, Jeong Eun Yoo, Songmi Noh, Dai Hoon Han, Young Nyun Park
Gut and Liver.2019; 13(1): 83.     CrossRef
Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension
Ran Kim, Woo Kyoung Jeong, Tae Wook Kang, Kyoung Doo Song, Min Woo Lee, Soo Hyun Ahn, Hyunchul Rhim
Acta Radiologica.2019; : 028418511984283.     CrossRef
Analyses of a Panel of Transcripts Identified From a Small Sample Size and Construction of RNA Networks in Hepatocellular Carcinoma
Zhiyong Sheng, Xiaolin Wang, Geliang Xu, Ge Shan, Liang Chen
Frontiers in Genetics.2019;[Epub]     CrossRef
Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
Bo Hyun Kim, Joong-Won Park, Jin Sook Kim, Sook-Kyung Lee, Eun Kyung Hong
Gut and Liver.2019; 13(3): 342.     CrossRef
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Jun Sik Yoon, Byeong Geun Song, Jeong-Hoon Lee, Hyo Young Lee, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon
BMC Cancer.2019;[Epub]     CrossRef
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau, Chiun Hsu, Tae-You Kim, Su-Pin Choo, Yoon-Koo Kang, Ming-Mo Hou, Kazushi Numata, Winnie Yeo, Akhil Chopra, Masafumi Ikeda, Ryoko Kuromatsu, Michihisa Moriguchi, Yee Chao, Huanyu Zhao, Jeffrey Anderson, Christine Dela Cruz, Masatoshi Kudo
Journal of Hepatology.2019; 71(3): 543.     CrossRef
The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease
H. Taflin, L. Hafström, E. Holmberg, M. Castedal, P. Lindnér
Scandinavian Journal of Gastroenterology.2019; 54(6): 746.     CrossRef
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis
David Sooik Kim, Tae Seop Lim, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Oidov Baatarkhuu, Seung Up Kim
Digestive Diseases and Sciences.2019;[Epub]     CrossRef
Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
Yu Young Joo, Jeong Won Jang, Sung Won Lee, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Scientific Reports.2019;[Epub]     CrossRef
Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma
Jong Man Kim, Jae-Won Joh, Nam-Joon Yi, Gyu-Seong Choi, Kyunga Kim, Kwang-Woong Lee, Kyung-Suk Suh
Journal of Gastrointestinal Surgery.2019;[Epub]     CrossRef
Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations
Won Hyeok Choe, Ki Jeong Kim, So Young Lee, Yu Min Choi, So Young Kwon, Jeong Han Kim, Bum Joon Kim
World Journal of Gastroenterology.2019; 25(33): 4985.     CrossRef
The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity
Jae Hyun Park, Dong Hwi Kim, Sung Hoon Kim, Moon Young Kim, Soon Koo Baik, In Su Hong
World Journal of Surgery.2018; 42(5): 1514.     CrossRef
18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
Pil Soo Sung, Hye Lim Park, Keungmo Yang, Seawon Hwang, Myeong Jun Song, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ie Ryung Yoo, Si Hyun Bae
European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(3): 384.     CrossRef
Contrast-enhanced ultrasound of malignant liver lesions
Isabelle Durot, Stephanie R. Wilson, Jürgen K. Willmann
Abdominal Radiology.2018; 43(4): 819.     CrossRef
Novel biomarkers in hepatocellular carcinoma
Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly
Digestive and Liver Disease.2018; 50(11): 1115.     CrossRef
Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
Soon Sun Kim, Hyo Jung Cho, Ji Sun Nam, Hyun Ji Kim, Dae Ryong Kang, Je Hwan Won, Jinoo Kim, Jai Keun Kim, Jei Hee Lee, Bo Hyun Kim, Mi Young Lee, Sung Won Cho, Jae Youn Cheong
Journal of Korean Medical Science.2018;[Epub]     CrossRef
Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance
Chung Seop Lee, Yong Jin Jung, Soon Sun Kim, Jae Youn Cheong, Ga Ram Lee, Han Gyeol Kim, Beom Hee Kim, Jung Wha Chung, Eun Sun Jang, Sook-Hyang Jeong, Kyung Ho Lee, Jin-Wook Kim, Ferruccio Bonino
PLOS ONE.2018; 13(1): e0190261.     CrossRef
Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population
Bo Hyun Kim, Young-Suk Lim, Eun-Yang Kim, Hyun-Joo Kong, Young-Joo Won, Seungbong Han, Sohee Park, Jae Seok Hwang
Journal of Gastroenterology and Hepatology.2018; 33(2): 475.     CrossRef
Prolongation of liver-specific function for primary hepatocytes maintenance in 3D printed architectures
Yohan Kim, Kyojin Kang, Sangtae Yoon, Ji Sook Kim, Su A. Park, Wan Doo Kim, Seung Bum Lee, Ki-Young Ryu, Jaemin Jeong, Dongho Choi
Organogenesis.2018; 14(1): 1.     CrossRef
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016
Song-Huy Nguyen-Dinh, Albert Do, Trang Ngoc Doan Pham, Doan Y Dao, Trinh Nhu Nguy, Moon S Chen Jr
World Journal of Hepatology.2018; 10(1): 116.     CrossRef
Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Jung Hee Kim, Dong Hyun Sinn, Jeong-Hoon Lee, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Young Chang, Yoon Jun Kim, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Digestive Diseases and Sciences.2018; 63(4): 1062.     CrossRef
ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma
Seong K. Na, Sun Y. Yim, Sang J. Suh, Young K. Jung, Ji H. Kim, Yeon S. Seo, Hyung J. Yim, Jong E. Yeon, Kwan S. Byun, Soon H. Um
Journal of Surgical Oncology.2018; 117(5): 912.     CrossRef
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim
Gut and Liver.2018; 12(2): 190.     CrossRef
Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
Jong Man Kim, Nam-Joon Yi, Choon Hyuck David Kwon, Kwang-Woong Lee, Kyung-Suk Suh, Jae-Won Joh
Annals of Surgical Treatment and Research.2018; 94(3): 129.     CrossRef
Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance
Y. E. Chon, K. S. Jung, M.-J. Kim, J.-Y. Choi, C. An, J. Y. Park, S. H. Ahn, B. K. Kim, S. U. Kim, H. Park, S. K. Hwang, K. S. Rim, K.-H. Han, D. Y. Kim
Alimentary Pharmacology & Therapeutics.2018; 47(8): 1201.     CrossRef
Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein
Jin Hyoung Kim, Ju Hyun Shim, Hyun‐Ki Yoon, Heung‐Kyu Ko, Jong Woo Kim, Dong Il Gwon
Liver International.2018; 38(9): 1646.     CrossRef
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kwang Min Kim, Jiyu Kim, Dong Hyun Sinn, Hye Seung Kim, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2018; 53(6): 727.     CrossRef
Alpha-fetoprotein in pericardial, peritoneal, and pleural fluids: A body fluid matrix evaluation
William E. Owen, Joshua J.H. Hunsaker, Jonathan R. Genzen
Clinical Biochemistry.2018; 56: 109.     CrossRef
Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma
Yuri Jeong, Jinhong Jung, Byungchul Cho, Jungwon Kwak, Chiyoung Jeong, Jong Hoon Kim, Jin-hong Park, So Yeon Kim, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sang Min Yoon
BMC Cancer.2018;[Epub]     CrossRef
Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells
Jiao Li, Dan-Dan Wu, Ji-Xiang Zhang, Jing Wang, Jing-Jing Ma, Xue Hu, Wei-Guo Dong
World Journal of Gastroenterology.2018; 24(17): 1901.     CrossRef
Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade
Hajime Matsushima, Yuko Takami, Tomoki Ryu, Munehiro Yoshitomi, Masaki Tateishi, Yoshiyuki Wada, Hideki Saitsu
Journal of Gastrointestinal Surgery.2018; 22(7): 1230.     CrossRef
Hepatocellular Carcinoma: Review of Targeted and Immune Therapies
Daniel da Motta Girardi, Tatiana Strava Correa, Marcela Crosara Teixeira, Gustavo Dos Santos Fernandes
Journal of Gastrointestinal Cancer.2018; 49(3): 227.     CrossRef
Post-operative care of interventional therapy for 40 liver cancer patients with obstructive jaundice
De-ping Tong, Li-qin Wu, Xiao-ping Chen, Yi Li
European Journal of Cancer Care.2018; 27(4): e12858.     CrossRef
Percutaneous US/MRI Fusion–guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes
Kyoung Doo Song, Min Woo Lee, Hyunchul Rhim, Tae Wook Kang, Dong Ik Cha, Dong Hyun Sinn, Hyo Keun Lim
Radiology.2018; 288(3): 878.     CrossRef
Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA–Enhanced Magnetic Resonance Images
Jinhong Jung, Hojin Kim, Sang Min Yoon, Byungchul Cho, Yeon Joo Kim, Jungwon Kwak, Jong Hoon Kim
International Journal of Radiation Oncology*Biology*Physics.2018; 102(4): 867.     CrossRef
Subcentimeter Hepatocellular Carcinoma: A New Paradigm for Treatment with Percutaneous Radiofrequency Ablation?
Johannes T. Heverhagen, Slavka Kudrnová
Radiology.2018; 288(3): 887.     CrossRef
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho
Cancer Chemotherapy and Pharmacology.2018; 82(3): 469.     CrossRef
Mitochondria-targeting nanoparticles for enhanced microwave ablation of cancer
Xiaowei Chen, Changhui Fu, Yaqin Wang, Qirun Wu, Xianwei Meng, Ke Xu
Nanoscale.2018; 10(33): 15677.     CrossRef
Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy
Brian E. Kouri
Techniques in Vascular and Interventional Radiology.2018; 21(4): 205.     CrossRef
Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer
Chai Hong Rim, Sangjoon Park, Joong Yeol Woo, Jinsil Seong
Strahlentherapie und Onkologie.2018; 194(11): 1017.     CrossRef
Hepatocellular carcinoma treatment: hurdles, advances and prospects
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera
Hepatic Oncology.2018; 5(2): HEP08.     CrossRef
Correlation between Resection Margin and Disease Recurrence with a Restricted Cubic Spline Model in Patients with Resected Hepatocellular Carcinoma
Woohyung Lee, Ho-Seong Han, Soyeon Ahn, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi
Digestive Surgery.2018; 35(6): 520.     CrossRef
Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration
Sumin Lee, Hojin Kim, Yunseo Ji, Byungchul Cho, Su Ssan Kim, Jinhong Jung, Jungwon Kwak, Jin-hong Park, Sang-wook Lee, Jong Hoon Kim, Sang Min Yoon
Scientific Reports.2018;[Epub]     CrossRef
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
Jongmoo Park, Jinhong Jung, Daegeun Kim, In-Hye Jung, Jin-hong Park, Jong Hoon Kim, Sang-wook Lee, Sang Min Yoon
BMC Cancer.2018;[Epub]     CrossRef
Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
Min Young Baek, Jeong-Ju Yoo, Soung Won Jeong, Jae Young Jang, Yong Kwon Kim, Shin Ok Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Su Yeon Park
The Korean Journal of Internal Medicine.2018;[Epub]     CrossRef
Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
Minjong Lee, Young Chang, Sohee Oh, Young Youn Cho, Dhong-Eun Jung, Hong Hyun Kim, Joon Yeul Nam, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Nam-Joon Yi, Kwang-Woong Lee, Dong Ho Lee, Jeong Min Lee, Jung-Hwan Yoon, Kyung-Suk Suh, Yoon Jun Kim
Gut and Liver.2018; 12(5): 571.     CrossRef
A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma
Yao Liu, Le Sun, Fangyuan Gao, Xue Yang, Yuxin Li, Qun Zhang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Ying Feng, Yuyong Jiang, Xianbo Wang
Medicine.2018; 97(49): e13536.     CrossRef
Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
Min Woo Lee, Hyo Keun Lim
World Journal of Gastroenterology.2018; 24(46): 5215.     CrossRef
Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area
Jung Ho Im, Sang Min Yoon, Hee Chul Park, Jong Hoon Kim, Jeong Il Yu, Tae Hyun Kim, Jun Won Kim, Taek-Keun Nam, Kyubo Kim, Hong Seok Jang, Jin Hee Kim, Mi-Sook Kim, Won Sup Yoon, Inkyung Jung, Jinsil Seong
Liver International.2017; 37(1): 90.     CrossRef
Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver
Hyo Jung Cho, Bohyun Kim, Jung-Dong Lee, Dae Ryong Kang, Jai Keun Kim, Jei Hee Lee, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho
American Journal of Gastroenterology.2017; 112(3): 460.     CrossRef
Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment
Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Hee Jung Wang, Bong Wan Kim, Jung-Dong Lee, Dae Yong Kang, Ji Hyun Kim, Yang Min Jae, Jae Chul Hwang, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong
Clinics and Research in Hepatology and Gastroenterology.2017; 41(2): 181.     CrossRef
Development and application of micro-polysaccharide drug carriers incorporating doxorubicin and superparamagnetic iron oxide for bimodality treatment of hepatocellular carcinoma
Sung-Ling Tang, Meng-Yi Bai, Jyun-Yi Wang, Po-Da Hong
Colloids and Surfaces B: Biointerfaces.2017; 151: 304.     CrossRef
Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis
Jeong Eun Yoo, Young-Joo Kim, Hyungjin Rhee, Haeryoung Kim, Ei Yong Ahn, Jin Sub Choi, Massimo Roncalli, Young Nyun Park, Taro Yamashita
PLOS ONE.2017; 12(1): e0170465.     CrossRef
Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area
Dong Hyeon Lee, Jeong-Hoon Lee, Yong Jin Jung, Jungsoo Gim, Won Kim, Byeong Gwan Kim, Kook Lae Lee, Yuri Cho, Jeong-Ju Yoo, Minjong Lee, Young Youn Cho, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu
PLOS ONE.2017; 12(1): e0170394.     CrossRef
Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure
Yohan Kim, Kyojin Kang, Jaemin Jeong, Seung Sam Paik, Ji Sook Kim, Su A Park, Wan Doo Kim, Jisun Park, Dongho Choi
Annals of Surgical Treatment and Research.2017; 92(2): 67.     CrossRef
The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
Jung Hee Kim, Dong Hyun Sinn, Sung Wook Shin, Sung Ki Cho, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Clinical and Molecular Hepatology.2017; 23(1): 42.     CrossRef
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
Wonhee Hur, Jae Yong Ryu, Hyun Uk Kim, Sung Woo Hong, Eun Byul Lee, Sang Yup Lee, Seung Kew Yoon
Scientific Reports.2017;[Epub]     CrossRef
Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis
Benbo Zheng, Rongce Zhao, Xiaodong Li, Bo Li
Surgical Endoscopy.2017; 31(11): 4641.     CrossRef
A model predicting survival of patients with recurrent or progressive hepatocellular carcinoma: the MORE score
Sang Il Choi, Ami Yu, Bo Hyun Kim, Eun Jeong Ko, Soon Seob Park, Byung-Ho Nam, Joong-Won Park
Journal of Gastroenterology and Hepatology.2017; 32(3): 651.     CrossRef
3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
Minjong Lee, Ara Jo, Seulki Lee, Jong Bin Kim, Young Chang, Joon Yeul Nam, Hyeki Cho, Young Youn Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Yuan-Soon Ho
PLOS ONE.2017; 12(3): e0174271.     CrossRef
Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years
J.G. Park, S.Y. Park, W.Y. Tak, Y.O. Kweon, S.Y. Jang, Y.R. Lee, K. Hur, H.J. Lee, H.W. Lee
Clinical Radiology.2017; 72(8): 692.e9.     CrossRef
Letter to the Editor, Re: Cadier et al. (2017)
Chibuzo Iloabuchi, Amanda Stover, Pragya Rai, Yifan Zhang, Khalid M. Kamal
Hepatology.2017; 66(1): 299.     CrossRef
Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma
Shin Ok Jeong, Eui Bae Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Dong Erk Goo, Su Yeon Park
Gut and Liver.2017; 11(3): 409.     CrossRef
Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma
Suk-Won Suh, Yoo Shin Choi
Yonsei Medical Journal.2017; 58(4): 737.     CrossRef
Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation
Elisabeth G. Klompenhouwer, Raphaëla C. Dresen, Chris Verslype, Annouschka Laenen, Gert De Hertogh, Christophe M. Deroose, Lawrence Bonne, Vincent Vandevaveye, Geert Maleux
CardioVascular and Interventional Radiology.2017; 40(12): 1882.     CrossRef
Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
Binghua Li, Wendu Feng, Ouyang Luo, Tiancheng Xu, Yajuan Cao, Hongyan Wu, Decai Yu, Yitao Ding
Scientific Reports.2017;[Epub]     CrossRef
Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma
Andrej Khandoga, Moritz Drefs, Markus Schoenberg, Tobias Schiergens, Katharina Frenes, Mark op den Winkel, Christoph Trumm, Martin K. Angele, Markus Guba, Jens Werner, Markus Rentsch
European Journal of Gastroenterology & Hepatology.2017; 29(9): 1045.     CrossRef
Percutaneous Dual-Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: A Preliminary Study
Tae Won Choi, Jeong Min Lee, Dong Ho Lee, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Joon Koo Han
Korean Journal of Radiology.2017; 18(5): 799.     CrossRef
Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma
Seung Kak Shin, Yun Soo Kim, Young Sup Shim, Seung Joon Choi, So Hyun Park, Dong Hae Jung, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim
Medicine.2017; 96(33): e7761.     CrossRef
Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective anal
Sung Won Lee, Hae Lim Lee, Nam Ik Han, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Therapeutic Advances in Medical Oncology.2017; 9(10): 615.     CrossRef
Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma
Jennifer Eatrides, Emilie Wang, Nishi Kothari, Richard Kim
Cancer Control.2017; 24(3): 107327481772924.     CrossRef
Refining the management of patients with hepatocellular carcinoma integrating 11C-choline PET/CT scan into the multidisciplinary team discussion
Ezio Lanza, Matteo Donadon, Paolo Felisaz, Antonio Mimmo, Arturo Chiti, Guido Torzilli, Luca Balzarini, Egesta Lopci
Nuclear Medicine Communications.2017; 38(10): 826.     CrossRef
Liver Function Assessment Using Albumin–Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
In Soo Oh, Dong Hyun Sinn, Tae Wook Kang, Min Woo Lee, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2017; 62(11): 3235.     CrossRef
Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma
Pegah Golabi, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi
Annals of Hepatology.2017; 16(4): 555.     CrossRef
Comparison of laparoscopic liver resection for hepatocellular carcinoma located in the posterosuperior segments or anterolateral segments: A case-matched analysis
Woohyung Lee, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi, Hong Kyung Shin, Jae Yool Jang, Hanlim Choi, Jae Seong Jang, Seong Uk Kwon
Surgery.2016; 160(5): 1219.     CrossRef
Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Jung-Hwan Yoon
Biomedicine & Pharmacotherapy.2016; 83: 607.     CrossRef
Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma
Young-Hsiang Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee, Bing-Jie Shen, Liang-Cheng Chen, Dai-Wei Liu, Wei-Ta Tsai, Po-Hao Lin, Yi-Ting Shih, Feng-Chun Hsu, Shiang-Jiun Tsai, Michael W.Y. Chan, Hon-Yi Lin
Medicine.2016; 95(34): e4717.     CrossRef
Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria
Jung Hee Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Ki Yeon Kim, Kyunga Kim, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Medicine.2016; 95(35): e4735.     CrossRef
Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
Yuri Cho, Dong Hyun Sinn, Su Jong Yu, Geum Youn Gwak, Ji Hoon Kim, Yang Jae Yoo, Dae Won Jun, Tae Yeob Kim, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu
PLOS ONE.2016; 11(11): e0165722.     CrossRef